March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
In 2005 the Women and HIV Think Tank changed its name to WRI to reflect the work of the group and ongoing commitment to measurable results in the management of HIV disease in women.
Just test positive for HIV? Look here for help on next steps, normal feelings, and finding support.
Learn about reasonable accommodation in the workplace, your rights by law as a person living with HIV, and how to take care of yourself at work.